John Chiosi (@Keyosee) header
John Chiosi (@Keyosee) profile picture

John Chiosi

@Keyosee

Infectious Diseases doc @mgh_id via @MGHBWHIDFellows @TulaneMedPeds @IcahnMountSinai. Modeling outcomes of infxns from IDU @mgh_mpec. Views mine. #GirlDad 🇵🇷

 NYC-NOLA-BOS
connects.catalyst.harvard.edu/Profiles/display/Person/183603
Joined March 2010
  • Tweets596
  • Following1.2K
  • Followers671
97Media
Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)Photo by John Chiosi (@Keyosee)
A few yrs ago, ⁦@IDDoc1978⁩ gathered a group of ID/SUD physicians ⁦@IDWeekmtg⁩, & ID-CIRCUS was born: the ID Coalition for improving Care 4 ppl using Substances. This yr, Dr Madeline McCrary made us official with swag 🎪. This is the energy we need to transform care!
Image from Ellen Eaton (@DrEllenEaton)
2
3
1
29
1,712
Wow! Waiting for PURPOSE-4 results to come out for #PWID. Another group consistently excluded from trials.
This Post is from an account that no longer exists. Learn more
4
1,324
Thrilled to welcome our new @MGHBWHIDFellows to @MassGeneralNews today! 🎉 On to @bwh_id tomorrow!
Image from MGH Division of Infectious Diseases (@mgh_id)
1
6
62
3,183
I’m just a doctor, in a state w/o Medicaid expansion, trying to get access to long-acting, injectable buprenorphine for my patients. Between insurance access, prior authorizations, & pharmacy limitations, it shouldn’t be this hard 2 get lifesaving meds for ppl w/ addiction in AL
8
18
72
4,291
Love that substance use and infections is well represented at #CROI2024! Really enjoying this session, “Hazards Ahead: The Intersection of HIV and Substance Use.” Here are the highlights: – at Denver, CO
1
1
7
991
more replies
Amanda Miller from SDSU showed how alcohol use is a predictor of poor HIV care outcomes in women living with HIV (WLWH) in Uganda. Of 304 WLWH in the study, 👉 18% w hazardous alcohol use 👉 alcohol use associated with 3x odds of detectable viral load at 12mo – at Denver, CO
1
1
169
Daniel Foster from Hosp Germans Trias i Pujol showed association of alcohol w mortality in PWH in Spain. 👉 4.3% drinking >40g/d. 26% in PWID. 👉 MR for >40g/d was 2.09 (RR 4.85) 👉 ⬆️ mortality w >40g/day (HR 4.28), HCV (HR 5.05), CD4 below median (HR 2.58), PWID (HR 4.72) – at Denver, CO
1
122
Really thankful for @CFAR_ISURC putting together a wonderful networking session during #CROI2024. Great catching up with old friends and making new ones! – at Denver, CO
1
1
421
It is so cool when you get to work with people fierce about health equity for people who use drugs. @KinnaThakarar @JayCdoesID @AyeshaAppaMD and Kathleen Fairfield, Jessica Brown, Amelia Goff, Chasity Tuell. INSERT FIRE EMOJI HERE x 3. academic.oup.com/cid/advance…
Image from Alysse Wurcel MD MS FIDSA (@IDDoc1978)
3
18
1
69
20,348
Congrats to the new ID fellows and WELCOME!!!! 🫶 #IDtwitter – at Boston, MA
MGH Division of Infectious Diseases (@mgh_id) profile pictureMGH Division of Infectious Diseases@mgh_id29 Nov 2023
Image from MGH Division of Infectious Diseases (@mgh_id)
1
19
3,606
Excited to share new research out today @JAMANetworkOpen with @emilyhyle @aimaMDMPH @AnkurFactorial and team at @mgh_mpec. 1/8 dlvr.it/SzR2cB
Image from Katherine Rich (@katherinemrich)
3
9
3
28
10,631
John Chiosi retweeted
NIDAnews (@NIDAnews) profile picture
NIDAnews
@NIDAnews21 Sep 2023
Join the next #NIDA #HIV Seminar on October 25 at 11 AM ET 🗓️ with Dr. Monica Gandhi and Dr. Katerina Christopoulos from @UCSF discussing Long-Acting ART for Vulnerable Populations. loom.ly/bI6d_eM
Graphic that reads: NIDA HIV SEMINAR SERIES. In red box, "'Long-Acting ART for Vulnerable Populations: Practical Considerations'" Wednesday, October 25 11:00 A.M. EDT Featuring guest speaker Monica Gandhi, M.D., M.P.H., Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco. Also featuring guest speaker Katerina Christopoulos, M.D., M.P.H., Professor of Medicine in that division, as well as an infectious disease physician. Learn more & Register: bit.ly/octoberhivseminar Images of Dr. Gandhi and Dr. Christopoulos on the right side with a red ribbon and NIDA HIV Research Program underneath.

ALT Graphic that reads: NIDA HIV SEMINAR SERIES. In red box, "'Long-Acting ART for Vulnerable Populations: Practical Considerations'" Wednesday, October 25 11:00 A.M. EDT Featuring guest speaker Monica Gandhi, M.D., M.P.H., Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco. Also featuring guest speaker Katerina Christopoulos, M.D., M.P.H., Professor of Medicine in that division, as well as an infectious disease physician. Learn more & Register: bit.ly/octoberhivseminar Images of Dr. Gandhi and Dr. Christopoulos on the right side with a red ribbon and NIDA HIV Research Program underneath.

3
5
1,866
A new narrative review offers guidance on the care of patients exposed to #xylazine, or #tranq, an animal sedative that has made its way into the illicitly manufactured #fentanyl supply: ow.ly/7zKt50PVc3r
Image from Annals of Int Med (@AnnalsofIM)
4
6
3,220
Tennessee’s rejection of CDC EHE funding cannot be justified on clinical, epidemiological, economic grounds, MPEC investigators find. Presented by Dr. Ethan Borre as a late-breaking abstract @IDweekmtg
Dr. Ethan Borre presenting at ID Week. Image includes presentation's conclusion slide, which reads: "Reallocation of HIV prevention funding in Tennessee (1) would greatly harm people at risk for acquiring HIV; (2) would confer minimal benefits for first-responders, pregnant people and survivors of sex trafficking; and (3) cannot be justified on clinical, epidemiologic, or economic grounds."

ALT Dr. Ethan Borre presenting at ID Week. Image includes presentation's conclusion slide, which reads: "Reallocation of HIV prevention funding in Tennessee (1) would greatly harm people at risk for acquiring HIV; (2) would confer minimal benefits for first-responders, pregnant people and survivors of sex trafficking; and (3) cannot be justified on clinical, epidemiologic, or economic grounds."

1
12
1
16
13,302
Dr. Sarah Zambrano did an awesome job delivering her platform presentation on our use of dalbavancin in patients who use and do not use drugs at BWH, MGH, and NWH. #IDWeek2023
Image from Brandon Dionne (@BWDionne)
Image from Brandon Dionne (@BWDionne)
2
15
1,354
Really great oral abstract by @edward_traver at #IDWeek2023 on his INJECT-RESPECT tool for assessing risks of IDU. We need to approach these discussions with respect and dignity. Looking forward to see how we can incorporate this into our EMR @mgh_id @IDWeekmtg – at Boston, MA
1
6
465
Load more